Literature DB >> 6072575

Potency and time-effect relationship in man of propranolol and H 56-28--comparative studies after oral administration.

B Ablad, G Johnsson, A Norrby, L Sölvell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6072575     DOI： 10.1111/j.1600-0773.1967.tb02999.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

2.  [Modification of sympathetic hyperactivity by drugs. Short-term pharmacologic experiments using parasympathomimetics and beta-receptor blockaders in humans].

Authors:  A W von Eiff; A Czernik; K Zanders
Journal:  Klin Wochenschr       Date:  1969-07-01

3.  Intrinsic sympathomimetic activity of penbutolol.

Authors:  G Nyberg; C Wilhelmsson; A Vedin
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

5.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M L Orme; M D Rawlins; J Ostman
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

6.  Comparison of the effects of propranolol and MJ 1999 on cardiac beta-adrenoceptors in man.

Authors:  J M Kofi Ekue; D C Lowe; R G Shanks
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.